Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17201416rdf:typepubmed:Citationlld:pubmed
pubmed-article:17201416lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:17201416lifeskim:mentionsumls-concept:C0076552lld:lifeskim
pubmed-article:17201416lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:17201416pubmed:issue1lld:pubmed
pubmed-article:17201416pubmed:dateCreated2007-1-4lld:pubmed
pubmed-article:17201416pubmed:abstractTextThe metabolism of our prototypical thrombin receptor antagonist 1, Ki = 2.7 nM, was studied and three major metabolites (2, 4, and 5) were found. The structures of the metabolites were verified independently by synthesis. Compound 4 was shown to be a potent antagonist of the thrombin receptor with a Ki = 11 nM. Additionally, compound 4 showed a 3-fold improvement in potency with respect to 1 in an agonist-induced ex-vivo platelet aggregation assay in cynomolgus monkeys after oral administration; this activity was sustained with 60% inhibition observed at 24 h post-dose. Compound 4 was highly active in functional assays and showed excellent oral bioavailability in rats and monkeys. Compound 4 showed a superior rat enzyme induction profile relative to compound 1, allowing it to replace compound 1 as a development candidate.lld:pubmed
pubmed-article:17201416pubmed:languageenglld:pubmed
pubmed-article:17201416pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:citationSubsetIMlld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17201416pubmed:statusMEDLINElld:pubmed
pubmed-article:17201416pubmed:monthJanlld:pubmed
pubmed-article:17201416pubmed:issn0022-2623lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:OrrV BVBlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:HsiehYunsheng...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:Chackalamanni...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:GreenleeWilli...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:LauJaniceJlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:KaoGraceGlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:BryantMatthew...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:FosterCarolyn...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:YanXiaXlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:PalamandaJair...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:ChintalaMadhu...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:Smith-TorhanA...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:AhnHo-SamHSlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:BoykowGeorgeGlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:AltonKevinKlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:DollerDarioDlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:CzarnieckiMic...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:TsaiHsinganHlld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:Agans-Fantuzz...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:ClasbyMartin...lld:pubmed
pubmed-article:17201416pubmed:authorpubmed-author:EagenKeithKlld:pubmed
pubmed-article:17201416pubmed:issnTypePrintlld:pubmed
pubmed-article:17201416pubmed:day11lld:pubmed
pubmed-article:17201416pubmed:volume50lld:pubmed
pubmed-article:17201416pubmed:ownerNLMlld:pubmed
pubmed-article:17201416pubmed:authorsCompleteYlld:pubmed
pubmed-article:17201416pubmed:pagination129-38lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:meshHeadingpubmed-meshheading:17201416...lld:pubmed
pubmed-article:17201416pubmed:year2007lld:pubmed
pubmed-article:17201416pubmed:articleTitleMetabolism-based identification of a potent thrombin receptor antagonist.lld:pubmed
pubmed-article:17201416pubmed:affiliationCentral Nervous System and Cardiovascular Chemical Research, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.lld:pubmed
pubmed-article:17201416pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17201416pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17201416lld:chembl